MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q3
hinzugefügt 14.11.2022
Calithera Biosciences EV/EBITDA 2011-2026 | CALA
EV/EBITDA Jährlich Calithera Biosciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.96 | -1.1 | -2.51 | -1.91 | -7.28 | -3.18 | -2.6 | -11.9 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.1 | -11.9 | -4.81 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M |  USA |
 |
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M |  Germany |
 |
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | USA |
 |
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M |  Canada |
 |
I-Mab
IMAB
|
595 | - | - | $ 866 M |  China |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | USA |
 |
Aptorum Group Limited
APM
|
29.4 | $ 0.84 | 2.78 % | $ 4.58 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | USA |
 |
Adagene
ADAG
|
-4.92 | $ 2.95 | 10.3 % | $ 166 M | China |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | USA |
 |
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Amarin Corporation plc
AMRN
|
123 | $ 15.08 | 2.24 % | $ 6.15 B |  Irlanda |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.51 | -1.68 % | $ 8.45 B |  Australia |
 |
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | USA |
 |
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | USA |
 |
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | Canada |
 |
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | USA |
 |
Athira Pharma
ATHA
|
-3.66 | - | - | $ 269 M | USA |
 |
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | USA |
 |
Brickell Biotech
BBI
|
0.668 | - | -5.38 % | $ 6.06 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - |  Russia |
 |
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-15.7 | $ 222.25 | 0.1 % | $ 5 B |  Danmark |
 |
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | USA |
 |
Aravive
ARAV
|
-0.158 | - | -13.39 % | $ 1.45 M | USA |
 |
BioNTech SE
BNTX
|
4.1 | $ 109.88 | -0.42 % | $ 27.2 B | Germany |
 |
Arena Pharmaceuticals
ARNA
|
-9.01 | - | -6.81 % | $ 3.04 B | USA |
 |
BeiGene, Ltd.
BGNE
|
-208 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Aridis Pharmaceuticals
ARDS
|
-0.807 | - | 17.91 % | $ 11.1 M | USA |
 |
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | USA |
 |
Athersys
ATHX
|
0.437 | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | USA |
 |
Baudax Bio
BXRX
|
-1.99 | - | 0.59 % | $ 63 K | USA |
 |
Cabaletta Bio
CABA
|
0.778 | $ 2.64 | 7.99 % | $ 3.08 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 4.4 | 2.8 % | $ 9.57 B |  Israel |
 |
Autolus Therapeutics plc
AUTL
|
-1.38 | $ 1.44 | -1.37 % | $ 367 M | Britain |
 |
Amneal Pharmaceuticals
AMRX
|
1.63 | $ 14.79 | 1.83 % | $ 4.57 B | USA |
 |
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | USA |
 |
AVROBIO
AVRO
|
0.957 | - | 1083.1 % | $ 745 M | USA |
 |
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | Germany |
 |
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | USA |